TEL: +44 208 7482 221
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
When it comes to medical aesthetic treatments, patients are always looking for solutions that not only deliver results, but that also help them save time, whether it’s through shorter treatments or fewer visits to the clinic. This is where a treatment like TriBella™ by Venus Versa™ can offer significant benefits. TriBella™ is a tri-modality treatment protocol for total skin renewal with remarkable clinical outcomes.
TriBella™ with Venus Versa™, our leading multi-platform device, is the ultimate facial rejuvenation protocol that has produced great results even just after one treatment. To help our customers learn more about the value of the treatment and the Venus Versa™ platform, we turned to Michael Gold, MD, FAAD, a renowned dermatologist and cosmetic surgeon and the founder of multiple practices in Nashville Tennessee, including the Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and the Tennessee Clinical Research Center. In this webinar, Dr. Gold discussed the profound results produced by TriBella™ treatments and what it’s done for his aesthetics business. Watch the full webinar below.
The innovative TriBella™ protocol combines three different treatments with three unique technologies in one session for synergistic improvements in patients’ skin texture, tone, and tightness. The first step is an IPL photorejuvenation treatment to target unwanted pigmentation in the skin. The second step is an anti-aging treatment with the DiamondPolar™ applicator, equipped with our proprietary (MP)2 technology (Multi-Polar Radio Frequency + Pulsed Electro Magnetic Fields) to smoothen out fine lines and wrinkles while firming up lax skin. Last but not least, the NanoFractional RF™ applicator for skin resurfacing is used to even out the overall texture and complexion of the skin.
In addition to helping you deliver the best treatments for your patients with cutting-edge technology, we are also committed to ensuring that your practice is financially successful, which is why we offer the industry’s first and only true subscription-based acquisition model backed by unparalleled clinical, technical, and business development support. Discover your options with Venus Concept today by contacting an expert using the button below.
For more information call: (+44) 208 748 2221 // info.uk@venusconcept.com
REGULATORY CLEARANCES [ More ]
Venus Versa™ has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick. The AC Dual applicator has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ applicator has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The OctiPolar™ applicators on the Venus Versa™ system has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Bliss™ has CE Mark as a non-invasive medical aesthetic device enabling a comprehensive approach leading to body contouring, addressing fat reduction, skin tightening, circumference reduction, and cellulite reduction.
ARTAS iX™ has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ has CE Mark for the increase of skin tightening, temporary circumferential reduction, cellulite reduction, and wrinkle reduction.
Venus Velocity™ has CE Mark for treatment of hirsutism (hair removal), permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Viva™ has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Epileve™ has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types. Venus Epileve™ is also CE-Marked for hirsutism.
Venus Freeze Plus™ has CE Mark for treatment of moderate to severe facial wrinkles and rhytides using the DiamondPolar™ applicator, and CE Mark for the treatment of cellulite reduction, increase of skin tightening, and temporary circumferential reduction on the OctiPolar™ applicator.
Venus Glow™ provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click Here